What is the direction of the big health industry in 2020? What is the layout?

Introduction of the big health industry to grasp the two ends of the spectrum, an old and a young (aging and reproductive health), to grasp the middle-aged anxiety, such as occupational diseases, this is the current direction of the big health industry, in the pharmaceutical industry, medical device industry, medical services industry, medical research and development services outsourcing industry and so on is a small success, so how is the direction of the big health industry in 2020? How is the layout? Here we come to a specific understanding.

1, the pharmaceutical industry

Macromolecule biopharmaceuticals & gt; small molecule chemical drugs & gt; health care supplements & gt; traditional medicine. Cardiovascular disease, diabetes and other chronic diseases and cancer are aging diseases. Pharmaceutical industry due to policy-oriented to promote competition between pharmaceutical companies, then large head generic drug companies > single product innovative drug companies > generic drug companies > intermediates API companies. Here to explain the head of generic drugs better than single product innovative drugs because innovation requires a lot of investment and a long cycle, time is uncertainty, is the risk, so the head of the generic drug companies slightly better. In addition, generic drugs in the long run, the price must fall, the need to make up for the old product decadence shrinkage through the introduction of new products, and then through the research and development of generic drug profit cycle, and gradually make the pharmaceutical manufacturing enterprises step into the field of innovative drugs. Why not directly recommend large innovative drug companies? This type of enterprise is not seen in the country for the time being, most of the main domestic pharmaceutical enterprises are still in the generic.

2, medical devices

Cardiac stent class has been somewhat more, imaging is also. So the medical device trend a IVD, that is, in vitro diagnostics, the popular field is instant detection POCT, such as rapid blood test, this industry in depth, including a certain array of biochips, microfluidic chips and test strips. In this blood glucose testing threshold is the lowest, but the demand is the largest. Then there are skeletal implants, one of which is joint implants and spinal implants, which are highly technical implants, and the other angle is actually dentistry. There are also artificial heart valves in cardiology, pacemakers, which are technically difficult. There's also large medical monitoring equipment and hemodialysis.

3, medical services

Three major industries have the most market, dental, ophthalmology and beauty. Overall beauty business is more risky and less transparent, but girls like us not to deny that the overall development is not benign enough. But dentistry and ophthalmology have been very popular, in this case belong to the daily needs of life. Dental implants are expensive, and the trend today is towards low-loss restorations. Refractive surgery in ophthalmology is very popular and technically difficult. There is also genetic testing precision medicine, but this part of the enterprise is still in a pathfinder, we still do not have mature rules to protect our genetic privacy, and in fact, the demand for genetic testing is not too common, the future demand will be more, maternity testing, early cancer screening and gene therapy are needed. There is also the health insurance industry, which is booming today. This fits the anxiety of middle-aged people, the backbone of the family. Don't be broke if you don't have anything, and don't be sick if you do.

4, medical research and development services outsourcing industry

Including preclinical and clinical data, most of which are categorized as CRO, this industry is relatively some future, but the future is built on the premise of the global user base. It is also to go out and cooperate with large pharmaceutical companies. There is also a medical information technology, the concept of electronic medical records, but at this stage of medical personal information specification has not been done, the hospitals will not promote the patient's personal information **** enjoy, between different hospitals you have to repeat the examination, so the temporary observation period.

In summary, health care is a huge field, aging will promote the increase in total medical expenditure, this is certain, but to understand the Japanese medicine of the price of single product expenditure is declining, the last few years of longevity of the Japanese people in the drug spending on expenditure is still declining, although not much, but enough to promote the competition of pharmaceutical companies in the R & D. So Japanese pharmaceutical enterprises R & D investment is very huge. In addition, personal superstition a little, did not go through the painstaking research and development of drugs, should not be promoted, or should not be sold as prescription drugs. In the future, the development of the health industry will only get better and better, and will also get more national policy support oh!